C-Reactive Protein-to-Lymphocyte Ratio as a Prognostic Biomarker in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy: A Multicenter Study
Authors:
- Hasan DoganHasan Dogan
- Ozkan OzmukOzkan Ozmuk
- Zülfikar MemişZülfikar Memiş
- Bilgehan Atilgan AcarBilgehan Atilgan Acar
- Emrah AytacEmrah Aytac
- Ferhat BalgetirFerhat Balgetir
- Aysenur OnalanAysenur Onalan
- Ozlem AykacOzlem Aykac
- Zehra Uysal KocabasZehra Uysal Kocabas
- Muhammed Nur OgunMuhammed Nur Ogun
- Esra ÜnalEsra Ünal
- Cetin Kursad AkpinarCetin Kursad Akpinar
Open Access
- 13 November 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (22) , 2872
Abstract
Background/Objectives: The C-reactive protein-to-lymphocyte ratio (CLR) has emerged as an inflammatory biomarker reflecting innate and adaptive immune responses. Its prognostic value in acute ischemic stroke patients undergoing mechanical thrombectomy remains unclear. This study investigated whether CLR predicts functional outcome, mortality, and symptomatic intracranial hemorrhage (sICH). Methods: In this multicenter retrospective study, 714 patients with anterior circulation large-vessel occlusion treated with mechanical thrombectomy between January 2024 and January 2025 were analyzed. Clinical, angiographic, and laboratory data, including CLR, were collected. CLR was calculated as CRP divided by lymphocyte count/1000. Outcomes were 90-day modified Rankin Scale (mRS; poor outcome = 3–6; mortality = 6) and sICH per ECASS II. Receiver operating characteristic (ROC) analyses identified optimal CLR cut-offs. Logistic regression analyses determined independent predictors of outcomes. Results: sICH occurred in 39 patients (5.5%). CLR correlated with higher baseline NIHSS and lower ASPECTS. ROC analyses showed that CLR predicted poor functional outcome and mortality with an identical cut-off (≥7.51; AUCs 0.634 and 0.664), and demonstrated strong discrimination for sICH (cut-off ≥ 10.64; AUC 0.855). In multivariable analyses, CLR remained an independent predictor across all outcomes (ORs 1.02, 1.02, and 1.03, all p < 0.001), in addition to established clinical factors. Conclusions: Admission CLR was independently associated with poor outcomes, mortality, and sICH after mechanical thrombectomy. As an easily obtainable marker from routine laboratory tests, CLR may provide additional prognostic information and complement established predictors, but prospective validation is required.Keywords
This publication has 44 references indexed in Scilit:
- The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre studyJournal of the Neurological Sciences, 2025
- High C-Reactive Protein/ Albumin Ratio Predicts Mortality and Hemorrhage in Stroke Patients Undergoing Mechanical Thrombectomy: A Systematic Review and Meta-AnalysisWorld Neurosurgery, 2024
- Postoperative fibrinogen‐to‐albumin ratio acting as an indicator of futile recanalization in patients with successful thrombectomyBrain and Behavior, 2023
- The predictive power of C‐reactive protein‐ lymphocyte ratio for in‐hospital mortality after colorectal cancer surgeryCancer Reports, 2021
- Cortisol is More Important than Metanephrines in Driving Changes in Leukocyte Counts after StrokeJournal of Stroke and Cerebrovascular Diseases, 2018
- Stroke and the immune system: from pathophysiology to new therapeutic strategiesThe Lancet Neurology, 2011
- C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and deathJournal of Neurology, 2009
- Prognostic value of admission C-reactive protein in stroke patients undergoing IV thrombolysisJournal of Neurology, 2008
- Catecholamines, infection, and death in acute ischemic strokeJournal of the Neurological Sciences, 2007
- An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosisJournal of Neuroimmunology, 2003